PALISADE CAPITAL MANAGEMENT, LP - HORIZON PHARMA INVT LTD ownership

HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 36 filers reported holding HORIZON PHARMA INVT LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of HORIZON PHARMA INVT LTD
ValueSharesWeighting
Q1 2020$6,593,000
-11.5%
5,603,0000.0%0.23%
+10.4%
Q4 2019$7,448,000
+13.8%
5,603,0000.0%0.21%
+5.5%
Q3 2019$6,546,000
+5.4%
5,603,0000.0%0.20%
+4.2%
Q2 2019$6,212,000
-2.3%
5,603,0000.0%0.19%
-5.9%
Q1 2019$6,356,000
+13.6%
5,603,0000.0%0.20%
-0.5%
Q4 2018$5,595,000
-11.6%
5,603,000
-10.8%
0.20%
+17.1%
Q3 2018$6,332,000
+5.0%
6,278,0000.0%0.18%
+0.6%
Q2 2018$6,031,000
+4.2%
6,278,0000.0%0.17%
-11.2%
Q1 2018$5,788,000
-0.8%
6,278,0000.0%0.20%
-1.0%
Q4 2017$5,835,000
+2.6%
6,278,0000.0%0.20%
-2.0%
Q3 2017$5,686,000
+4.7%
6,278,0000.0%0.20%
-1.0%
Q2 2017$5,430,000
-5.8%
6,278,0000.0%0.20%
-7.7%
Q1 2017$5,766,000
-3.7%
6,278,0000.0%0.22%
-1.8%
Q4 2016$5,989,000
-2.0%
6,278,000
-0.1%
0.22%
+3.7%
Q3 2016$6,114,000
+4.5%
6,284,000
-2.0%
0.22%
+2.4%
Q2 2016$5,851,000
+27.0%
6,412,000
+18.7%
0.21%
+40.4%
Q1 2016$4,606,0005,403,0000.15%
Other shareholders
HORIZON PHARMA INVT LTD shareholders Q1 2018
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 99,100,000$94,914,0003.33%
Lion Point Capital, LP 16,000,000$15,312,0001.38%
SYMPHONY ASSET MANAGEMENT LLC 5,000,000$4,804,0000.96%
LINDEN ADVISORS LP 32,106,000$30,888,0000.95%
OAKTREE CAPITAL MANAGEMENT LP 46,262,000$44,449,0000.62%
Nicholas Investment Partners, LP 8,635,000$8,264,0000.58%
ADVENT CAPITAL MANAGEMENT /DE/ 16,785,000$16,100,0000.34%
CANYON CAPITAL ADVISORS LLC 30,000,000$28,712,0000.32%
SSI INVESTMENT MANAGEMENT LLC 3,250,000$3,110,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 6,278,000$6,031,0000.17%
View complete list of HORIZON PHARMA INVT LTD shareholders